India to Vietnam: Ritonavir Export Trade Route
India has recorded 10 verified shipments of Ritonavir exported to Vietnam, representing a combined trade value of $21.3M USD. This corridor is served by 1 active Indian exporters, with an average shipment value of $2.1M USD. The leading Indian exporter is CIPLA LIMITED, which accounts for 100% of total export value with 10 shipments worth $21.3M USD. On the buying side, CENTRAL PHARMACEUTICAL CPC1. JSC is the largest importer in Vietnam with $10.9M USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Vietnam Ritonavir corridor is one of India's established pharmaceutical export routes, with 10 shipments documented worth a combined $21.3M USD. The route is dominated by CIPLA LIMITED, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's ritonavir manufacturing sector.
Across 1 active suppliers, the average shipment value stands at $2.1M USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 80% of all shipments, consistent with ritonavir's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 34 days port-to-port. The route has recorded an annual growth rate of 20.0%, placing it at rank #16 among India's top ritonavir export destinations globally.
On the import side, key buyers of Indian ritonavir in Vietnam include CENTRAL PHARMACEUTICAL CPC1. JSC, CENTRAL PHARMACEUTICAL CPC1.JSC, CENTRAL PHARMACEUTICALCPC1JSC(CPC1) and 3 others. CENTRAL PHARMACEUTICAL CPC1. JSC is the single largest importer with 2 shipments valued at $10.9M USD.
Route Characteristics
- Average transit34 days
- Peak seasonQ1
- Primary modeSea freight
- Top portCOCHIN SEA
Market Position
- Global rank#16
- Annual growth+20.0%
- Demand growth+18.9%
- Regulatory ease84/100
Top 10 Indian Ritonavir Exporters to Vietnam
Showing top 10 of 1 Indian suppliers exporting Ritonavir to Vietnam, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | CIPLA LIMITED Avg $2.1M per shipment | 10 | $21.3M | 100.0% |
This table shows the top 10 of 1 Indian companies exporting ritonavir to Vietnam, ranked by total trade value. The listed exporters are: CIPLA LIMITED. CIPLA LIMITED is the dominant supplier with 10 shipments worth $21.3M USD, giving it a 100% market share.
Top 10 Ritonavir Importers in Vietnam
Showing top 10 of 6 known buyers in Vietnam receiving Ritonavir shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian ritonavir in Vietnam include CENTRAL PHARMACEUTICAL CPC1. JSC, CENTRAL PHARMACEUTICAL CPC1.JSC, CENTRAL PHARMACEUTICALCPC1JSC(CPC1), CENTRAL PHARMACEUTICAL, CENTRAL PHARMACEUTICAL CPC1., among 6 total buyers. The largest importer is CENTRAL PHARMACEUTICAL CPC1. JSC, accounting for $10.9M USD across 2 shipments — representing 51% of all ritonavir imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | CENTRAL PHARMACEUTICAL CPC1. JSC | 2 | $10.9M | 51.3% |
| 2 | CENTRAL PHARMACEUTICAL CPC1.JSC | 2 | $10.1M | 47.2% |
| 3 | CENTRAL PHARMACEUTICALCPC1JSC(CPC1) | 2 | $135.8K | 0.6% |
| 4 | CENTRAL PHARMACEUTICAL | 2 | $89.6K | 0.4% |
| 5 | CENTRAL PHARMACEUTICAL CPC1. | 1 | $52.3K | 0.2% |
| 6 | CENTRAL PHARMACEUTICAL CPC1. JSC(CP | 1 | $52.0K | 0.2% |
Top 10 Ritonavir Formulations Imported by Vietnam
Showing top 10 of 10 product formulations shipped on the India to Vietnam Ritonavir route, ranked by trade value
Vietnam imports a wide range of ritonavir formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — LOPIMUNE 200/50MG TABLETS (LOPINAVIR 200MG+RITONAVIR 50MG) (1995 PACK X 1X120'S=239400 NOS) — accounts for $5.5M USD across 1 shipments. A total of 10 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | LOPIMUNE 200/50MG TABLETS (LOPINAVIR 200MG+RITONAVIR 50MG) (1995 PACK X 1X120'S=239400 NOS) | 1 | $5.5M | 25.8% |
| 2 | LOPIMUNE 200/50MG TABLETS (LOPINAVIR 200MG+RITONAVIR 50MG) (1965 PACK X 1X120'S=235800 NOS) | 1 | $5.4M | 25.4% |
| 3 | LOPIMUNE 200/50MG TABLETS (LOPINAVIR 200MG+RITONAVIR 50MG) (1920 PACKX1X120'S=230400 NOS) | 1 | $5.3M | 24.9% |
| 4 | LOPIMUNE 200/50MG TABLETS (LOPINAVIR 200MG+RITONAVIR 50MG) (1725 PACKX1X120'S=207000 NOS) | 1 | $4.8M | 22.3% |
| 5 | LOPIMUNE 200/50MG TABLETS (LOPINAVIR 200MG+RITONAVIR 50MG)(2370 PACKS X1X120S=284400 NOS) | 1 | $68.4K | 0.3% |
| 6 | LOPIMUNE 200/50MG TABLETS (LOPINAVIR 200MG+RITONAVIR 50MG)(2325 PACKS X1X120S=279000 NOS) | 1 | $67.5K | 0.3% |
| 7 | LOPIMUNE 200/50MG TABLETS (LOPINAVIR 200MG+RITONAVIR 50MG) (1 X 120'S X 2325 Pack =279000 NOS) | 1 | $52.3K | 0.2% |
| 8 | LOPIMUNE 200/50MG TABLETS (LOPINAVIR 200MG+RITONAVIR 50MG) [PAC SIZE:1X120X2310PAC=277200 NOS] | 1 | $52.0K | 0.2% |
| 9 | LOPIMUNE 200/50MG TABLETS LOPINAVIR 200MG+RITONAVIR 50MG2139 PACKx1X120'S=256680NOS | 1 | $49.1K | 0.2% |
| 10 | LOPIMUNE 200/50MG TABLETS LOPINAVIR 200MG+RITONAVIR 50MG1770 PACKx1X120'S=212400 NOS | 1 | $40.6K | 0.2% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 80%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
COCHIN SEA handles the highest volume with 4 shipments. Transit time averages 34 days by sea.
Market Dynamics
India's ritonavir exports to Vietnam are driven primarily by a handful of large-scale manufacturers. CIPLA LIMITED with 10 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — buyers in Vietnam benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — CIPLA LIMITED — together account for 100% of total trade value on this route. The average shipment value of $2.1M USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as lopimune 200/50mg tablets (lopinavir 200mg+ritonavir 50mg) (1965 pack x 1x120's=235800 nos) and lopimune 200/50mg tablets (lopinavir 200mg+ritonavir 50mg) (1920 packx1x120's=230400 nos), suggesting that buyers in Vietnam tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, CENTRAL PHARMACEUTICAL CPC1. JSC is the largest importer with 2 shipments worth $10.9M USD — representing 51% of all ritonavir imports from India on this route. A total of 6 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $21.3M
- Avg. Shipment
- $2.1M
- Suppliers
- 1
- Buyers
- 6
- Transit (Sea)
- ~34 days
- Annual Growth
- +20.0%
Other Ritonavir Routes
Unlock the Full India to Vietnam Ritonavir Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 10 shipments on this route.
Frequently Asked Questions — India to Vietnam Ritonavir Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Ritonavir to Vietnam?
The leading Indian exporters of Ritonavir to Vietnam are CIPLA LIMITED. CIPLA LIMITED holds the largest market share at approximately 100% of total trade value on this route.
Q What is the total value of Ritonavir exports from India to Vietnam?
India exports Ritonavir to Vietnam worth approximately $21.3M USD across 10 recorded shipments. The average value per shipment is $2.1M USD.
Q Which ports does India use to ship Ritonavir to Vietnam?
The most active port of origin is COCHIN SEA with 4 shipments. Indian exporters primarily use sea freight for this route, with 80% of shipments going by sea and 26% by air.
Q How long does shipping take from India to Vietnam for Ritonavir?
The average transit time for Ritonavir shipments from India to Vietnam is approximately 34 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the India to Vietnam Ritonavir trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 20.0% with demand growth tracking at 18.9%. The route is ranked #16 among India's top Ritonavir export destinations globally.
Q How many suppliers are active on the India to Vietnam Ritonavir route?
There are currently 1 active Indian suppliers exporting Ritonavir to Vietnam. The market is moderately concentrated with CIPLA LIMITED accounting for 100% of total shipment value.
Q Who are the main importers of Ritonavir from India in Vietnam?
The leading importers of Indian Ritonavir in Vietnam include CENTRAL PHARMACEUTICAL CPC1. JSC, CENTRAL PHARMACEUTICAL CPC1.JSC, CENTRAL PHARMACEUTICALCPC1JSC(CPC1), CENTRAL PHARMACEUTICAL, CENTRAL PHARMACEUTICAL CPC1.. CENTRAL PHARMACEUTICAL CPC1. JSC is the largest buyer with 2 shipments worth $10.9M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Vietnam export trade corridor identified from Indian Customs (DGFT) records for Ritonavir.
- 2.Supplier/Buyer Matching: 1 Indian exporters and 6 importers in Vietnam matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 10 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
10 Verified Shipments
1 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists